chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DEAD FROM THE BOOSTER; This spontaneous report received from a consumer via a company representative via social media  concerned a 57 year old male of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously received covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, 1 total, start therapy date were not reported, for prophylactic vaccination (Dose number in series 1). No adverse event reported with previously treated with covid-19 vaccine ad26. cov2. s. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, 1 total administered on 11-DEC-2021 for prophylactic vaccination (Dose number series 2). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 13-DEC-2021, the patient died due to unspecified cause (Dose number series 2). As per report, "My friend that was only 57, he took the Booster on Saturday and his wife went to wake him up on Monday morning and he was dead from the booster". It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0:20211229888-COVID-19 VACCINE AD26.COV2.S-Dead from the booster. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
This spontaneous report as received from a consumer (patient's mother) refers to a male patient of unknown age. The patient did not have any pertinent medical history, drug reactions and allergies. On 16-APR-2008, the patient was vaccinated with M-M-R II (dose and route were not reported). The patient did not take any concomitant medications. On an unknown dates in 2008, after receiving the initial dose of M-M-R II the patient experienced chronic fevers that lasted for about 4 days and developed every 3-4 weeks. This last for one year before he stopped developing fevers. Treatment was given for the event and no lab lasts tests were performed. The patient sought medical attention and spoke to the physician. The outcome of pyrexia was reported as recovered/resolved. The causal relationship between M-M-R II and chronic fever was not reported. Additional information is not expected as there is no consent to contact the physician.
patient lied and said he wanted a first dose moderna vaccine.  he was with his partner who also wanted a first dose .  later after billing vaccine it was determined that this patient had already gotten the first and second dose seven months ago
Patient reported a history of nervousness around needles and had passed out after an immunization in the past. I walked her through the immunization process and after administering her vaccine, I asked her if she was feeling ok before allowing her to leave the clinical room. She stated she was feeling ok so I instructed her to have a seat in the post-vaccination waiting area just outside the pharmacy for 30 minutes so we could observe her as a safety precaution. Shortly after sitting down, the patient fell off her chair. I ran out to check on her and found her unconscious and lying face down on the floor. As soon as I touched her shoulders she began to wake up and tried to get up. I asked her to remain laying down and offered to help her roll over onto her back. I asked her if she could tell me her name - she responded correctly. I asked if she knew  where she was and she correctly stated she was at store. I had her take some deep breaths until her color came back and when she asked if she could please sit up, I assisted her into her chair and asked a technician to get a bottle of water for her. She felt a little shaky so I continued to hold onto her shoulders until she felt completely stable. She was able to take a few sips of water which helped her feel more steady. EMS arrived and checked her blood pressure and blood glucose levels. She was cleared by EMS and chose not to go to the hospital for further care. I had her call a friend to drive her home and stay with her for a while to make sure she was ok.
Pt devel hives and injection site warmth, redness and swelling, twenty-four hours after vax.
Discovered a chicken pox blister on right leg below patella. Had chickenpox as child. Currently has headaches, not sure whether she has fever.
shingles; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On or about 23-APR-2014, he was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiry date were not provided) for the long-term prevention of shingles and zoster-related conditions, by a pharmacist in the pharmacy. On an unknown date, subsequent to zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by a healthcare provider for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, he had and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
The patient came into pharmacy to get their Covid vaccine booster. She had a caregiver with them and had to help them into the vaccine room. After the shot the patient had difficulty standing.  After 10-15 minutes they still had difficulty standing and was helped into the wheelchair. They left the pharmacy area. In the front of the store the patient became incoherent having difficulty speaking and was coming close to passing out. The patient's daughter was came in and the 911 was called. They patient was believed to have low blood pressure at this point and left the store via ambulance.
Mom called to report a temp of 101 degrees, a "pounding headache" started middle of the night 7-18-08.  ?Photophobia.
Patient woke up in night with arm in extreme pain when she rolled over on it. Left arm was swollen from shoulder to elbow. By the following morning she had swelling in her lymphnodes under the left arm and towards her left breast. She had no pain with movement of the arm but it was painful to touch.  She went to see her primary care provider on Monday, September 23rd. They decided to prescribe an oral steroid and as nsaid for the swelling, They determined it was a localized reaction to the vaccine. Dr has recommended patient come to office for prophylactic steroid prior to administration of second dose.
This spontaneous report as received from a healthcare worker refers to an approximately 1 year old patient of unknown gender. On 21-OCT-2013 at 17:30 the patient was administered with a MMR II (lot number J002505, expiry date 28-FEB-2015) (dosing regimen and frequency unknown) that was exposed to a cumulative time of 9.5 hours ate temperatures of 8.0 degrees centigrade to 13.9 degrees centigrade, on 07-OCT-2013 from 17:14 to 18:08 the vaccine experienced a temperature of 9.4 degrees centigrade, on 10-OCT-2013 from 09.50 to 13.26 the vaccine experienced a temperature of 13.9 degrees centigrade, on 14-OCT-2013 from 13.56 to 16.08 the vaccine experienced a temperature of 12.8 degrees centigrade, on 17-OCT-2013 from 08:38 to 09:44 the vaccine experienced a temperature of 9.7 degrees centigrade, on 18-OCT-213 from 11:50 to 13:08 the vaccine experienced a temperature of 9.7 degrees centigrade. This is one of the 17 reports received from same reporter. Additional information has been requested.
Right sided Bells Palsy with right facial droop and right eye ptosis. Also had headache. Currently on prednisone. Mild improvement noted
shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received treatment oral unknown medication three times a day. No concomitant medication were provided.
was in so much pain; chills; headache; his body felt like 100-year-old man's with arthritis; felt discomfort; stinging/hurts to move arm; swelling; felt lethargic; scratchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (stinging/hurts to move arm), VACCINATION SITE SWELLING (swelling), LETHARGY (felt lethargic), MYALGIA (was in so much pain) and CHILLS (chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Enlarged prostate and Acute arthritis.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (stinging/hurts to move arm), VACCINATION SITE SWELLING (swelling), LETHARGY (felt lethargic), VACCINATION SITE PRURITUS (scratchy) and DISCOMFORT (felt discomfort). On 21-Jan-2021, the patient experienced MYALGIA (was in so much pain), CHILLS (chills), HEADACHE (headache) and ARTHRALGIA (his body felt like 100-year-old man's with arthritis). At the time of the report, VACCINATION SITE PAIN (stinging/hurts to move arm), VACCINATION SITE SWELLING (swelling), LETHARGY (felt lethargic), MYALGIA (was in so much pain), CHILLS (chills), HEADACHE (headache), VACCINATION SITE PRURITUS (scratchy), ARTHRALGIA (his body felt like 100-year-old man's with arthritis) and DISCOMFORT (felt discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications included ibuprofen and icing at injection site. No concomitant medications were provided by reporter.
She has upset stomach; She can't eat and drink; She feels nauseated; She has headache; She started feeling her heart was racing; Patient had a sore right arm after receiving 2nd dose; Couldn't sleep at night; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Patient had a sore right arm after receiving 2nd dose), INSOMNIA (Couldn't sleep at night), ABDOMINAL DISCOMFORT (She has upset stomach), FEEDING DISORDER (She can't eat and drink) and PALPITATIONS (She started feeling her heart was racing) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (Patient had a sore right arm after receiving 2nd dose), INSOMNIA (Couldn't sleep at night) and PALPITATIONS (She started feeling her heart was racing). On 16-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (She has upset stomach), FEEDING DISORDER (She can't eat and drink), NAUSEA (She feels nauseated) and HEADACHE (She has headache). At the time of the report, PAIN IN EXTREMITY (Patient had a sore right arm after receiving 2nd dose), INSOMNIA (Couldn't sleep at night), ABDOMINAL DISCOMFORT (She has upset stomach), FEEDING DISORDER (She can't eat and drink), PALPITATIONS (She started feeling her heart was racing), NAUSEA (She feels nauseated) and HEADACHE (She has headache) outcome was unknown. Not Provided          No relevant concomitant medications were reported. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Patient states he went to bed with shivers.  He awoke in the middle of the night with mild headache, low grade fever.  In the morning he started to have muscle weakness and joint soreness, which led to a fall.  He went to the hospital and they admitted him on Tuesday, July 9th, 2019.  They ran several tests but everything came back normal.  He was released on Wednesday, July 10th  and made a full recovery.
Approximately 5 min following injection, pt reported that she felt her uvula was swelling with pruritus of the throat, and that the back of her tongue was tingling. She reported feeling dizzy, with a flushed sensation in her chest, tingling progressed to entire tongue and to lips. No angioedema or rash on exam, airway clear, VS stable, 02 on RA 96-99% (02 sat increased following admin of epi) HR 106-109, BP 155/90. Administered 0.3mg epi via autoinjector and 50mg diphenhydramine PO. Pt noted sensation in the sensations in her throat, tongue and lips was beginning to subside approximately 10min after admin of medications. Transported via ambulance to CVMC ED for observation and further tx.
Headache; Body aches; This is a spontaneous report from a contactable nurse. A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) intramuscular on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received vaccine (unspecified Pfizer vaccine) on 30Dec2020 within 4 weeks prior to the COVID vaccine. On 20Jan2021 the patient experienced headache and body aches. No treatment was received for the events. Post vaccination, the patient has been tested for COVID-19 (Nasal swab) on 21Jan2021, test result was negative. Patient was not pregnant. The facility where the vaccine was administered was in a Nursing Home/Senior Living Facility. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome of the events was recovering.   Information on lot number/batch number was requested.
Patients arm is swollen, sensitive to touch, itching and contains small blisters. Patient stated she has not put anything on it or treated it yet.
SORE ARM; This spontaneous report received from a female patient of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular) .5 ml, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 06-MAR-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
Patient developed a large welt (big raised rash) on arm extending from left shoulder to elbow, (Itching, pain).
This was a problem with administration not an adverse event.  When the vaccine was injected it came out the side of the syringe where the piece that holds the needle connects to the syringe.  So instead of being injected into the patients arm the vaccine leaked out of the syringe.
she is legally blind; felt a little tired; a little anxious; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for herself, a female patient of an unspecified age (reported as 63, no units) who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated she had the first dose of the vaccine and felt a little tired and a little anxious one day but she felt it was because she was nervous about getting it. The patient stated she was legally blind and it was hard for her to read some things. The patient asked how long side effects will last, if she would get any, and if how long do the symptoms last after the second dose. She also asked if one did not have any side effects after the first vaccine, could they still get side effects after the second. The patient asked if people can take their medications as usual after receiving the vaccine, and if she could take Tylenol after the vaccine if she get symptoms. The outcome of the events was unknown.   Information about lot/batch number has been requested.
A dose volume of 0.25 mL was used, this was an incorrect dose volume used on 11/20/2021. Correct dose volume should have been 0.5 mL for 3rd shot as part of primary series for moderately to severely immunocompromised individuals.
Heart palpitations; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches) and PALPITATIONS (Heart palpitations) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (Body aches). On 10-Feb-2021, the patient experienced PALPITATIONS (Heart palpitations). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Body aches) and PALPITATIONS (Heart palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Apr2022 as dose 4 (booster), single (Lot number: FM0698) at the age of 36 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Autoimmune disease" (unspecified if ongoing), notes: Autoimmune disease; "B12 deficiency" (unspecified if ongoing), notes: B12 deficiency. Concomitant medication(s) included: HYDROXYCHLOROQUINE, start date: 21Mar2022. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: 4 days after my first negative test; (26Jul2022) negative. Therapeutic measures were taken as a result of covid-19.  Clinical course: The patient received Paxlovid anti-viral COVID 19 Treatment which start date was 18Jul2022 and stop date was 23Jul2022. The patient was taking any other medications/products within 2 weeks of starting COVID-19 treatment. Patient previously received a COVID-19 Vaccine. After completing her Paxlovid prescription she tested negative about 3 days later, felt better for about 4 or 5 days and then woke up with symptoms again and tested positive 4 days after her first negative test. Have a slight fever, congestion and feel run down. AE start date was 29Jul2022. It was recovering. No treatment received for AE. No known allergies.  No follow-up attempts are possible. No further information is expected.
Headache (severe), Nausea, Chills.  These all started Saturday evening and lasted into Sunday. Patient was unable to get out of bed on Sunday.  On Monday, she felt better but still had headache (less severe) and it lasted into Tuesday.
Red, hot lt upper arm shoulder to antecubital area. 4Dec90 Deltoid area red, hot tender induration 15 cmX 15cm.
patient vaccinated at another location.  approx 7 days post vaccination was admitted to the hospital for increasing shortness of breath and leg pain and swelling.
fever overnight, barely coherent, lethargic, severe joint and muscle pain, headache, vomiting, no appetite, had covid in October
20MAY92 pt recvd Engerix-B & same day pt exp swelling of feet; rash in lower legs; dizziness; 22MAY92 exp petechia in inner part of groin; pt hospitalized overnight;
Approximately 8 to 10 green, watery, mucusy stools daily x 16 days. Has not yet resolved.
anemia; Severe menstrual bleeding that lasted for several weeks after the first dose; This is a spontaneous report from a non-contactable consumer (patient). A 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (at the age of 47-years-old) via an unspecified route of administration, administered in Arm Left on 17Jun2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient has no medical history and concomitant medications. The patient has no known allergies and no covid-19 prior to vaccination. The patient had no other vaccine in four weeks. The patient experienced severe menstrual bleeding that lasted for several weeks after the first dose on 21Jun2021. The patient's cycle is extremely regular otherwise. The event resulted in doctor or other healthcare professional office/clinic visit and was treated with "iron and progesterone, fixed anemia". The patient was not tested for covid-19 post vaccination. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recv vax on 12/7/98; on 12/8/98 pt exp swollen leg w/ erythema of anterior aspect upper thigh to knee & tender; tx=ice & Benadryl
I had a heart episode, high blood pressure, chronic headache upon awakening, I felt weak felt like I was gonna pass out, I felt faint sweaty, palpitations. I laid down in the shower. My arms went numb and tingly, I had pressure in my jaw. I called 911, the paramedics found me on my bedroom floor I lost consciousness, I went to hospital. They kept me in the ER for a few hours about 6-7 hours.